Antibodies that immunospecifically bind to trail receptors
First Claim
1. An isolated antibody or fragment thereof comprising amino acid residues 26–
- 35, 50–
66, 99–
107, 157–
170, 186–
192, and 225–
234 of SEQ ID NO;
43, wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of;
(a) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;
(b) a multimer of the polypeptide of (a);
(c) the polypeptide of (a) expressed on the surface of a cell; and
(d) the multimer of (b) expressed on the surface of a cell.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to antibodies and related molecules that immunospecifically bind to TRAIL receptor, TR4. Such antibodies have uses, for example, in the prevention and treatment of cancers and other proliferative disorders. The invention also relates to nucleic acid molecules encoding anti-TR4 antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention relates to methods and compositions for preventing, detecting, diagnosing, treating or ameliorating a disease or disorder, especially cancer and other hyperproliferative disorders, comprising administering to an animal, preferably a human, an effective amount of one or more antibodies or fragments or variants thereof, or related molecules, that immunospecifically bind to TRAIL receptor TR4.
-
Citations
205 Claims
-
1. An isolated antibody or fragment thereof comprising amino acid residues 26–
- 35, 50–
66, 99–
107, 157–
170, 186–
192, and 225–
234 of SEQ ID NO;
43, wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of;(a) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;(b) a multimer of the polypeptide of (a); (c) the polypeptide of (a) expressed on the surface of a cell; and (d) the multimer of (b) expressed on the surface of a cell. - View Dependent Claims (2, 3, 64, 65)
- 35, 50–
-
4. An isolated antibody or fragment thereof comprising ammo acid residues 1–
- 118 and 135–
245 of SEQ ID NO;
43, wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of;(a) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;(b) a multimer of the polypeptide of (a); (c) the polypeptide of (a) expressed on the surface of a cell; and (d) the multimer of (b) expressed on the surface of a cell. - View Dependent Claims (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 59, 60, 61, 62, 63, 66, 67)
- 118 and 135–
-
5. An isolated scFv comprising amino acid residues 1 to 245 of SEQ ID NO:
- 43.
- 36. The antibody expressed by the cell line of ATCC Deposit PTA-3570.
-
68. An isolated antibody or fragment thereof comprising an amino acid sequence selected from the group consisting of:
-
(a) an amino acid sequence that is at least 80% identical to the VH domain of SEQ ID NO;
43;(b) an amino acid sequence that is at least 80% identical to the VL domain of SEQ ID NO;
43; and(c) the amino acid sequence of both (a) and (b); wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of; (i) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;(ii) a multimer of the polypeptide of (i); (iii) the polypeptide of (i) expressed on the surface of a cell; and (iv) the multimer of (ii) expressed on the surface of a cell. - View Dependent Claims (69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109)
-
-
110. An isolated antibody or fragment thereof comprising amino acid residues 1–
- 118 and 135–
245 of SEQ ID NO;
42, wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of;(a) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;(b) a multimer of the polypeptide of (a); (c) the polypeptide of (a) expressed on the surface of a cell; and (d) the multimer of (b) expressed on the surface of a cell. - View Dependent Claims (111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145)
- 118 and 135–
-
146. An isolated antibody or fragment thereof comprising an amino acid sequence selected from the group consisting of:
-
(a) the VH domain of any one of SEQ ID NOs;
45, 46, 47, 48, 49, or 51;(b) the VL domain of any one of SEQ ID NOs;
45, 46, 47, 48, 49, or 51; and(c) the amino acid sequence of both (a) and (b); wherein said antibody or fragment thereof immunospecifically binds a TR4 protein selected from the group consisting of; (i) a polypeptide having the amino acid sequence of any one of amino acid residues 1 to 468 of SEQ ID NO;
1, amino acid residues 24 to 468 of SEQ ID NO;
1, amino acid residues 24 to 238 of SEQ ID NO;
1, and amino acid residues 109 to 240 of SEQ ID NO;
1;(ii) a multimer of the polypeptide of (i); (iii) the polypeptide of (i) expressed on the surface of a cell; and (iv) the multimer of (ii) expressed on the surface of a cell. - View Dependent Claims (147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181)
-
-
182. An isolated antibody selected from the group consisting of:
-
(a) the antibody expressed by the cell line of ATCC Deposit PTA-3571;
or(b) the antibody expressed by the cell line of ATCC Deposit PTA-3675. - View Dependent Claims (183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205)
-
Specification